BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17513310)

  • 61. Implications for clinical treatment from the micrometer site dosimetric calculations in boron neutron capture therapy.
    Nichols TL; Kabalka GW; Miller LF; McCormack MT; Johnson A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S161-3. PubMed ID: 19375932
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
    Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
    [TBL] [Abstract][Full Text] [Related]  

  • 63. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy.
    Capuani S; Gili T; Bozzali M; Russo S; Porcari P; Cametti C; D'Amore E; Colasanti M; Venturini G; Maraviglia B; Lazzarino G; Pastore FS
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):562-7. PubMed ID: 18793958
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BNCT for recurrent intracranial meningeal tumours - case reports.
    Stenstam BH; Pellettieri L; Sorteberg W; Rezaei A; Sköld K
    Acta Neurol Scand; 2007 Apr; 115(4):243-7. PubMed ID: 17376121
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice.
    Miura M; Morris GM; Micca PL; Nawrocky MM; Makar MS; Cook SP; Slatkin DN
    Br J Radiol; 2004 Jul; 77(919):573-80. PubMed ID: 15238404
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Toward prompt gamma spectrometry for monitoring boron distributions during extra corporal treatment of liver metastases by boron neutron capture therapy: a Monte Carlo simulation study.
    Khelifi R; Nievaart VA; Bode P; Moss RL; Krijger GC
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S359-61. PubMed ID: 19394243
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical results of BNCT for malignant brain tumors in children.
    Nakagawa Y; Kageji T; Mizobuchi Y; Kumada H; Nakagawa Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S27-30. PubMed ID: 19406652
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice.
    Wu H; Micca PL; Makar MS; Miura M
    Bioorg Med Chem; 2006 Aug; 14(15):5083-92. PubMed ID: 16651000
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Radiobiologic significance of response of intratumor quiescent cells in vivo to accelerated carbon ion beams compared with gamma-rays and reactor neutron beams.
    Masunaga S; Ando K; Uzawa A; Hirayama R; Furusawa Y; Koike S; Sakurai Y; Nagata K; Suzuki M; Kashino G; Kinashi Y; Tanaka H; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):221-8. PubMed ID: 18086390
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A treatment planning study on glioblastoma with different techniques using boron neutron capture therapy, 3-dimensional conformal radiotherapy, and intensity modulated radiotherapy.
    Jung SH; Yoon SM; Park SH; Choi IS; Kim JK; Choi EK; Ahn SD; Lee SW; Song SY; Kim JH
    Appl Radiat Isot; 2009; 67(7-8):1180-4. PubMed ID: 19321353
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of boron neutron capture therapy on liver metastases of colon adenocarcinoma: optical and ultrastructural study in the rat.
    Nano R; Barni S; Chiari P; Pinelli T; Fossati F; Altieri S; Zonta C; Prati U; Roveda L; Zonta A
    Oncol Rep; 2004 Jan; 11(1):149-53. PubMed ID: 14654918
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Boron neutron capture therapy at the crossroads: challenges and opportunities.
    Barth RF
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.
    Yang W; Wu G; Barth RF; Swindall MR; Bandyopadhyaya AK; Tjarks W; Tordoff K; Moeschberger M; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA; Wikstrand CJ
    Clin Cancer Res; 2008 Feb; 14(3):883-91. PubMed ID: 18245552
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Boron neutron capture therapy for papillary cystadenocarcinoma in the upper lip: a case report.
    Kimura Y; Ariyoshi Y; Miyatake S; Shimahara M; Kawabata S; Ono K
    Int J Oral Maxillofac Surg; 2009 Mar; 38(3):293-5. PubMed ID: 19179044
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Functional and histological changes in rat lung after boron neutron capture therapy.
    Kiger JL; Kiger WS; Riley KJ; Binns PJ; Patel H; Hopewell JW; Harling OK; Busse PM; Coderre JA
    Radiat Res; 2008 Jul; 170(1):60-9. PubMed ID: 18582158
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preliminary evaluations of the undesirable patient dose from a BNCT treatment at the ENEA-TAPIRO reactor.
    Ferrari P; Gualdrini G; Nava E; Burn KW
    Radiat Prot Dosimetry; 2007; 126(1-4):636-9. PubMed ID: 17704505
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of pneumoperitoneum on tumor growth and pattern of intra-abdominal tumor spreading: in vivo study of a murine model.
    Shen MY; Huang IP; Chen WS; Chang JT; Lin JK
    Hepatogastroenterology; 2008; 55(84):947-51. PubMed ID: 18705304
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spatial and spectral characteristics of a compact system neutron beam designed for BNCT facility.
    Ghassoun J; Chkillou B; Jehouani A
    Appl Radiat Isot; 2009 Apr; 67(4):560-4. PubMed ID: 19168369
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
    Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.